Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2021

01-12-2021 | Antidepressant Drugs | Research article

Sex hormone levels in females of different ages suffering from depression

Authors: Rong Lei, Yan Sun, Jiawen Liao, Yuan Yuan, Linlin Sun, Yugeng Liu, Xinyu Yang, Wenyou Ma, Zhenjian Yu

Published in: BMC Women's Health | Issue 1/2021

Login to get access

Abstract

Background

There are only a few studies on sex hormones in females of different ages suffering from depression, and their conclusions are not uniform until now. This study aimed to investigate the correlation between the severity of depression in females and factors such as sex hormones and differences in sex hormone levels in females of different ages, exploring variations after treatment.

Methods

A total of 169 females with depression were selected and divided into the first-episode (91 cases) and recurrent (78 cases) groups. Then, on the basis of their age, the first-episode patients were divided into the young (48 cases, age < 45 years), perimenopausal (20 cases, 45–55 years), and elderly groups (23 cases, age > 55 years); the patients with recurrent depression were classified into the young (37 cases, age < 45 years), perimenopausal (19 cases, 45–55 years), and elderly groups (22 cases, age > 55 years). The patients were assessed in accordance with the International Classification of Diseases of mental and behavioral disorders. The serum progesterone, prolactin, estradiol, and testosterone levels in the patients were measured, and differences in sex hormone levels of the groups were analyzed.

Results

The estradiol level was negatively correlated with age and the prolactin level was positively correlated with occupation. The severity of depression in females was found to be negatively correlated with age. The serum progesterone and estradiol levels in the young group were significantly higher than those in the elderly group, regardless of the first episode or recurrence. Estradiol levels in the perimenopausal and elderly groups with first-episode depression were significantly higher than those in the same group with recurrent depression. However, there was no significant difference in the serum progesterone, prolactin, estradiol, and testosterone levels in the recurrent group before and after treatment.

Conclusions

Sex hormone levels, especially estradiol, varied among females of different ages suffering from depression. Recurrent depression also has a certain effect on sex hormone levels in females. Not only should the age and relapse be considered when studying the sex hormone levels of females with depression, but also attention should be paid to whether the patients have used antidepressants before their sexual hormonal testing.
Literature
1.
Friedrich MJ. Depression is the leading cause of disability around the World. JAMA. 2017;317(15):1517.PubMed
2.
Holden C. Mental health. Global survey examines impact of depression. Science. 2000;288(5463):39–40.PubMedCrossRef
3.
4.
Wesselhoeft R, Pedersen CB, Mortensen PB, Mors O, Bilenberg N. Gender–age interaction in incidence rates of childhood emotional disorders. Psychol Med. 2015;45(04):829–39.
5.
Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154–62.PubMedCrossRef
6.
Cover KK, Maeng LY, Lebrón-Milad K, Milad MR. Mechanisms of estradiol in fear circuitry: implications for sex differences in psychopathology. Transl Psychiatry. 2014;4(8):e422.PubMedPubMedCentralCrossRef
7.
Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry. 2017;4(1):73–82.PubMedCrossRef
8.
Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012;169(5):465–75.PubMedPubMedCentralCrossRef
9.
10.
11.
Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry. 2015;172(3):227–36.PubMedPubMedCentralCrossRef
12.
Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry. 2003;160(8):1519–22.PubMedCrossRef
13.
de Villiers TJ, Hall JE, Pinkerton JV, Perez SC, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–5.PubMedCrossRef
14.
Szpunar MJ, Parry BL. A systematic review of cortisol, thyroid-stimulating hormone, and prolactin in peripartum women with major depression. Arch Womens Ment Health. 2018;21(2):149–61.PubMed
15.
Del Rio JP, Alliende MI, Molina N, Serrano FG, Molina S, Vigil P. Steroid hormones and their action in Women’s brains: the importance of hormonal balance. Front Public Health. 2018;6:141.PubMedPubMedCentralCrossRef
16.
Yin W, Gore AC. Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction. 2006;131(3):403–14.PubMedCrossRef
17.
Bromberger JT, Epperson CN. Depression during and after the Perimenopause: impact of hormones, genetics, and environmental determinants of disease. Obstet Gynecol Clin N Am. 2018;45(4):663–78.CrossRef
18.
Slavich GM, Sacher J. Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders. Psychopharmacology. 2019;236(10):3063–79.PubMedPubMedCentralCrossRef
19.
Li D, Li Y, Chen Y, Li H, She Y, Zhang X, Chen S, Chen W, Qiu G, Huang H. Neuroprotection of reduced thyroid hormone with increased estrogen and progestogen in postpartum depression. 2019;39(9).
20.
Erdincler D, Bugay G, Ertan T, Eker E. Depression and sex hormones in elderly women. Arch Gerontol Geriatr. 2004;39(3):239–44.PubMedCrossRef
21.
Zarate S, Stevnsner T, Gredilla R. Role of estrogen and other sex hormones in brain aging. Neuroprotection and DNA repair. Front Aging Neurosci. 2017;9:430.PubMedPubMedCentralCrossRef
22.
23.
Graham BM, Denson TF, Barnett J, Calderwood C, Grisham JR. Sex hormones are Associated With Rumination and Interact With Emotion Regulation Strategy Choice to Predict Negative Affect in Women Following a Sad Mood Induction. Front Psychol. 2018;9:937.PubMedPubMedCentralCrossRef
24.
Cao XJ, Huang XC, Wang X. Effectiveness of Chinese herbal medicine granules and traditional Chinese medicine-based psychotherapy for perimenopausal depression in Chinese women: a randomized controlled trial. Menopause. 2019;26(10):1193–203.PubMed
25.
Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause. 2018;25(1):109–20.PubMedCrossRef
26.
Shabel SJ, Proulx CD, Piriz J, Malinow R. Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment. Science. 2014;345(6203):1494–8.PubMedPubMedCentralCrossRef
27.
Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, Zarate CA Jr. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biol Psychiatry. 2017;81(10):886–97.PubMedCrossRef
28.
Zhang L, Hernandez VS, Swinny JD, Verma AK, Giesecke T, Emery AC, Mutig K, Garcia-Segura LM, Eiden LE. A GABAergic cell type in the lateral habenula links hypothalamic homeostatic and midbrain motivation circuits with sex steroid signaling. Transl Psychiatry. 2018;8(1):50.PubMedPubMedCentralCrossRef
29.
Hill RA. Interaction of sex steroid hormones and brain-derived neurotrophic factor-tyrosine kinase B signalling: relevance to schizophrenia and depression. J Neuroendocrinol. 2012;24(12):1553–61.PubMedCrossRef
30.
Morris RG, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 1986;319(6056):774–6.PubMedCrossRef
31.
Murphy DD, Cole NB, Greenberger V, Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci. 1998;18(7):2550–9.PubMedPubMedCentralCrossRef
32.
Hu M, Watson CJ, Kennedy RT, Becker JB. Estradiol attenuates the K+-induced increase in extracellular GABA in rat striatum. Synapse. 2006;59(2):122–4.PubMedCrossRef
33.
Strohle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, Holsboer F, Rupprecht R. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry. 1999;45(3):274–7.PubMedCrossRef
34.
Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP, et al. Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: a positron emission tomography study. Biol Psychiatry. 2015;78(8):534–43.PubMedCrossRef
35.
Jahn H. Steroid-synthesis inhibition in depression: a good idea? Lancet Psychiatry. 2016;3(2):92–3.PubMedCrossRef
36.
Monteagudo PT, Falcão AA, Verreschi IT, Zanella MT. The imbalance of sex-hormones related to depressive symptoms in obese men. Aging Male. 2016;19(1):20–6.PubMedCrossRef
37.
Stanikova D, Luck T, Bae YJ, Thiery J, Ceglarek U, Engel C, Enzenbach C, Wirkner K, Stanik J, Kratzsch J, et al. Increased estrogen level can be associated with depression in males. Psychoneuroendocrinology. 2018;87:196–203.PubMedCrossRef
38.
Castanho TC, Moreira PS, Portugal-Nunes C, Novais A, Costa PS, Palha JA, Sousa N, Santos NC. The role of sex and sex-related hormones in cognition, mood and well-being in older men and women. Biol Psychol. 2014;103:158–66.PubMedCrossRef
39.
Bevilacqua LA, Dulak D, Schofield E, Starr TD, Nelson CJ, Roth AJ, Holland JC, Alici Y. Prevalence and predictors of depression, pain, and fatigue in older- versus younger-adult cancer survivors. Psycho-oncology. 2018;27(3):900–7.PubMedPubMedCentralCrossRef
40.
Sengupta P, Benjamin AI. Prevalence of depression and associated risk factors among the elderly in urban and rural field practice areas of a tertiary care institution in Ludhiana. Indian J Public Health. 2015;59(1):3–8.PubMedCrossRef
41.
Tang M, Liu X-H, Han H-Y, Tang M-M, Wang Y-F, Zhang L-Z. Prevalence of depressive disorders among residents aged 55 or above in Chengdu area. Chin Mental Health J. 2001;02:103–6.
42.
de Kruif M, Molendijk ML, Haffmans PM, Spijker AT. Depression during the perimenopause. Tijdschr Psychiatr. 2015;57(11):795–804.PubMed
43.
Breuer B, Martucci C, Wallenstein S, Likourezos A, Libow LS, Peterson A, Zumoff B. Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women. Am J Geriatr Psychiatry. 2002;10(3):311–20.PubMedCrossRef
44.
Dording CM, Boyden SD. Depression, antidepressants, and sexual functioning. In: The Massachusetts General Hospital Guide to Depression: New Treatment Insights and Options. edn. Edited by Shapero BG, Mischoulon D, Cusin C. Cham: Springer International Publishing; 2019:123–137.
45.
Damoiseaux VA, Proost JH, Jiawan VC, Melgert BN. Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives. Clin Pharmacokinet. 2014;53(6):509–19.PubMedCrossRef
46.
Islin J, Munkboel CH, Styrishave B. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay. Toxicol In Vitro: Int J Publ Assoc BIBRA. 2018;47:63–71.CrossRef
47.
Lupu D, Sjödin MOD, Varshney M, Lindberg J, Loghin F, Rüegg J. Fluoxetine modulates sex steroid levels in vitro. Clujul Med. 2017;90(4):420–4.PubMedPubMedCentral
Metadata
Title
Sex hormone levels in females of different ages suffering from depression
Authors
Rong Lei
Yan Sun
Jiawen Liao
Yuan Yuan
Linlin Sun
Yugeng Liu
Xinyu Yang
Wenyou Ma
Zhenjian Yu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2021
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01350-0

Other articles of this Issue 1/2021

BMC Women's Health 1/2021 Go to the issue

Research article

The importance of patient engagement to quality of breast cancer care and health-related quality of life: a cross-sectional study among Latina breast cancer survivors in rural and urban communities

Research article

Development and validation of a short version of the Female Sexual Function Index in the Spanish population

Research article

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France

Research article

Predictors of postpartum family planning in Rwanda: the influence of male involvement and healthcare experience

Research article

Diné (Navajo) female perspectives on mother–daughter communication and cultural assets around the transition to womanhood: a cross-sectional survey

Research article

Comparison of various aspects of women’s lives between infertile and women with and without tubal ligation: a comparative cross-sectional study